Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $37.31M | $371.21M | -89.95% |
Operating Income | $-466.57M | $-222.54M | -109.66% |
Net Income | $-366.25M | $-153.61M | -138.43% |
EPS (Basic) | $-4.34 | $-1.94 | -123.71% |
EPS (Diluted) | $-4.34 | $-1.94 | -123.71% |
R&D Expense | $310.24M | $387.33M | -19.90% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.24B | $2.23B | +0.56% |
Current Assets | $1.94B | $1.91B | +1.52% |
Total Liabilities | $309.95M | $346.77M | -10.62% |
Current Liabilities | $87.78M | $108.79M | -19.31% |
Stockholders' Equity | $1.93B | $1.88B | +2.62% |
Cash & Equivalents | $298.26M | $389.48M | -23.42% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-142.77M | $-260.38M | +45.17% |
Investing Cash Flow | $-280.48M | $374.65M | -174.87% |
Financing Cash Flow | $331.98M | $62.66M | +429.78% |
D&A | $19.26M | $19.84M | -2.91% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1250.4% | -60.0% | -1190.43% |
Net Margin | -981.5% | — | — |
ROE | -19.0% | — | — |
ROA | -16.3% | — | — |
Current Ratio | $22.068 | — | — |
Debt to Equity | $0.16 | — | — |
Other companies in Biotechnology